Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyoscine Butyl Bromide
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Cara Care has teamed up with the Consumer Healthcare Business Unit of Sanofi Germany to provide Sanofi’s Buscomint® bei Reizdarm drug with Cara Care’s digital companion app for digestive conditions.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 22, 2020
Lead Product(s) : Hyoscine Butyl Bromide
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?